The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...

A recent federal district court ruling against the office overseeing the 340B Drug Pricing Program has opened the doors for hospitals to more broadly claim discounts, healthcare legal experts say. The ...

A federal appeals court ruled in favor of three drugmakers Jan. 30 in a case over requirements of whether they should give 340B drug pricing discounts to contract pharmacies. HHS filed suit against ...

HHS has filed a legal brief urging a federal judge to dismiss lawsuits brought by pharmaceutical companies challenging the agency’s stance on 340B rebate models. Here are four takeaways: In the brief, ...

An appeals court has upheld a lower court ruling on 340B that sided with drug manufacturers. At issue is whether pharmaceutical companies can limit distribution of discounted drugs in the 340B program ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...

The 340B program, intended to lower drug costs for low-income patients, often benefits hospitals more than patients. A lack of transparency allows some hospitals to profit from the program instead of ...